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Abstract Takotsubo cardiomyopathy (TTC) is still an
under-recognized disease and little data exists on the
coexistence of TTC and obstructive coronary artery dis-
ease. Our patient case of an 80-year-old female lady
highlights the impact of a positron emission tomography/
computed tomography (PET/CT) follow-up imaging study
to delineate this unique entity from acute coronary syn-
drome (ACS). Furthermore, we show for the first time that
coronary flow reserve and myocardial blood flow is glob-
ally impaired in TTC and not only restricted to the non-
contracting parts. This indicates a global microcirculatory
impairment effect of the heart in the acute stage of TTC.
Our case also demonstrates that a transient metabolic
defect is also involved in this disease. Follow-up imaging
by PET/CT in our patient case unmasked TTC and facili-
tated to exclude the differential diagnosis of ACS.
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Case report
An 80-year-old female patient was admitted to the emer-
gency room with acute chest pain and ST-segment eleva-
tion. Emergency coronary angiography revealed a single
70–90 % stenosis of the mid left anterior descending
(LAD) artery with TIMI III flow (Fig. 1a). The left ven-
tricular (LV) angiogram showed a large akinesia of the
apex involving the LV mid segments extending way
beyond the myocardial territory supplied by the LAD and a
hyperdynamic contraction of the LV base (Fig. 1a). LV-
function was markedly reduced (35 %). The patient
underwent coronary stenting of the LAD lesion. Echocar-
diography study on the next day revealed a fast recovery of
LV ejection fraction (52 %); however, regional wall
motion abnormalities were still present. An in-depth his-
tory of the patient’s emotional state disclosed that a sudden
illness of her husband’s with the diagnosis of a carcinoma
was identified as her emotional stressor. To differentiate
ACS from takotsubo cardiomyopathy (TTC) a combined
perfusion/metabolism positron emission tomography/com-
puted tomography (PET/CT) study using 13N-ammonia
(13N-NH3) and
18F-fluorodeoxyglucose (FDG) was per-
formed on the 7th post-interventional day and at follow-up
3 months later. At baseline, the 13N-ammonia-PET/CT
study demonstrated an extensive area of decreased tracer
uptake in the apex and midventricular segments without
reversibility during stress (adenosine) and a congruent
defect on FDG PET study (Fig. 1b). Hyperemic myocardial
blood flow (MBF) and coronary flow reserve (CFR) were
globally decreased in the apical, midventricular and basal
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Fig. 1 a Coronary angiography
demonstrating a 70–90 %
stenosis of the mid left anterior
descending artery (LAD)
(arrow) and left ventricular
angiography showing apical
ballooning pattern. b 13N-
ammonia-positron-emission-
tomography/computed-
tomography (PET/CT) during
pharmacological stress (upper
row), at rest (middle row), and
18F-fluorodeoxyglucose (FDG)
PET/CT (lower row) Baseline
Studies performed 7 days after
index event demonstrate a large
perfusion defect involving the
apex and midventricular
segments without reversibility
during stress (arrows) and a
matching defect on metabolic
study with FDG (arrows). Total
Myocardial blood flow (MBF)
at rest was elevated (1.5 mL/
min/g) with minimal increase
during pharmacological stress
(1.6 mL/min/g) and severely
reduced CFR. MBF
abnormalities affected similarly
apical, midventricular and basal
segments. c At 3 months
follow-up, the combined PET/
CT studies showed full recovery
of the perfusion defect on 13N-
NH3-PET (upper and middle
row) and metabolic defect on
FDG-PET (lower row). Resting
MBF (1.3 mL/min/g) was lower
and hyperemic MBF (2.3 mL/
min/g) returned to normal
values. Similarly, CFR was
increased significantly
compared to baseline values
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segments of the LV myocardium (Fig. 1B). The matched
FDG-PET/CT finding, as well as the globally impaired
hyperemic MBF and CFR, did not correspond to the ter-
ritory of a single coronary artery distribution. The PET/CT-
follow-up-study at 3 month documented full recovery
(Fig. 1c). Therefore, complete reversibility of the perfu-
sion, microcirculatory and metabolic defect suggests that
an acute anterior myocardial infarction due to the LAD
stenosis was unlikely the underlying cause of the large
akinesia of the apical and midventricular segments, but that
it rather represents TTC.
One proposed mechanism in TTC encompasses the cat-
echolamine spillover in which a direct cell toxic effect is
suggested through the cyclic-adenosine-monophosphate-
mediated calcium overload which decreases myocyte via-
bility [1]. The reduced FDG tracer uptake in the acute phase
of TTC has been referred to as the ‘‘metabolic trapping
effect’’ by which glucose is transiently trapped in the car-
diac tissue without further metabolism [2]. In this regard, it
has been demonstrated that catecholamines stimulates the
expression of cardiac glucose transporters through an alpha-
1adrenergic receptor mediated mechanism in isolated rat
cardiomyocytes [3]. However, the exact mechanism
remains unclear, although a, catecholamine-induced mi-
crocirculatory dysfunction has also been suggested as a
potential cause [4]. In fact in our study we observed a
perfusion and matched metabolic defect in the concordant
non contracting myocardial parts at baseline, while CFR
and MBF were globally impaired and not solely restricted to
the dysfunctional LV myocardium. Our findings indicate
that microcirculatory dysfunction is a global phenomenon
in TTC, though more severe in regions with contractile
dysfunction. In contrast, the glucose dysmetabolism was
limited to the morphologic dysfunctional myocardium.
Whether this contributes to the pathophysiology or
whether this is a secondary cause of TTC, this needs to be
elucidated.
Our study highlights the utility of PET/CT follow-up
imaging to delineate the unique entity of TTC from myo-
cardial infarction in patients with obstructive coronary
artery disease. Furthermore, we would like to emphasize
that—contrary to popular belief—TTC can infrequently
co-exist with obstructive CAD, as acknowledged in the
revised Mayo Clinic diagnostic criteria. Thus, we speculate
that myocardial infarction may be misdiagnosed in patients
with TTC who have concomitant obstructive CAD stenosis
in the LAD.
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